Results according to treatment arm in 319 assessable patients
| Result . | R-CHOP (n = 159) . | R-CHOP + RT (n = 160) . | ||
|---|---|---|---|---|
| No. . | % . | No. . | % . | |
| After cycle 4 | ||||
| CR | 137 | 86 | 144 | 90 |
| PR (PET-positive) | 22 | 14 | 16 | 10 |
| End of treatment | ||||
| CR | 150 | 94 | 157 | 98 |
| PR | 8 | 2 | ||
| Progression | 0 | 1 | ||
| Relapse | 13 | 8 | 10 | 6 |
| Secondary malignancy | 2 | 2 | ||
| Death | 12 | 8 | 9 | 6 |
| Result . | R-CHOP (n = 159) . | R-CHOP + RT (n = 160) . | ||
|---|---|---|---|---|
| No. . | % . | No. . | % . | |
| After cycle 4 | ||||
| CR | 137 | 86 | 144 | 90 |
| PR (PET-positive) | 22 | 14 | 16 | 10 |
| End of treatment | ||||
| CR | 150 | 94 | 157 | 98 |
| PR | 8 | 2 | ||
| Progression | 0 | 1 | ||
| Relapse | 13 | 8 | 10 | 6 |
| Secondary malignancy | 2 | 2 | ||
| Death | 12 | 8 | 9 | 6 |